|
MCM6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.7535000000366E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.222100E-04 |
| Normal-vs-Stage2 |
1.237950E-01 |
| Normal-vs-Stage3 |
3.643300E-04 |
| Normal-vs-Stage4 |
1.66182999999931E-05 |
| Stage1-vs-Stage2 |
3.667200E-01 |
| Stage1-vs-Stage3 |
3.080800E-01 |
| Stage1-vs-Stage4 |
1.200350E-02 |
| Stage2-vs-Stage3 |
1.668570E-01 |
| Stage2-vs-Stage4 |
7.856400E-03 |
| Stage3-vs-Stage4 |
1.107030E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.27610000003153E-06 |
| Normal-vs-AfricanAmerican |
8.812300E-02 |
| Normal-vs-Asian |
2.154600E-01 |
| Caucasian-vs-AfricanAmerican |
2.075800E-01 |
| Caucasian-vs-Asian |
5.903400E-01 |
| AfricanAmerican-vs-Asian |
3.128200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.06279999999115E-05 |
| Normal-vs-Female |
1.404480E-04 |
| Male-vs-Female |
9.221000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.119900E-02 |
| Normal-vs-Age(41-60Yrs) |
5.97169999999592E-05 |
| Normal-vs-Age(61-80Yrs) |
2.30270000000088E-05 |
| Normal-vs-Age(81-100Yrs) |
5.578800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.380600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.949000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.238400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.506000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.843420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.574390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.855030E-01 |
| Normal-vs-Grade 2 |
3.249900E-04 |
| Normal-vs-Grade 3 |
9.95759999999901E-05 |
| Normal-vs-Grade 4 |
7.7886000000027E-05 |
| Grade 1-vs-Grade 2 |
6.907800E-01 |
| Grade 1-vs-Grade 3 |
5.729800E-01 |
| Grade 1-vs-Grade 4 |
8.644000E-02 |
| Grade 2-vs-Grade 3 |
5.410000E-01 |
| Grade 2-vs-Grade 4 |
3.748100E-02 |
| Grade 3-vs-Grade 4 |
8.685700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.301500E-03 |
| Normal-vs-ccB subtype |
1.79704999999641E-05 |
| ccA subtype-vs-ccB subtype |
6.311700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.201590E-04 |
| Normal-vs-N1 |
2.901400E-03 |
| N0-vs-N1 |
3.763900E-03 |
|
|
